APO Research
Talk to an analyst

APO RESEARCH · REPORT

Budesonide Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Budesonide Capsules Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchBudesonide Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide Capsules Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Budesonide Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Budesonide Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Budesonide Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Budesonide Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Budesonide Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Budesonide Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Budesonide Capsules include Amneal, Mayne Pharma, Perrigo, Sciecure Pharma, Tillotts Pharma, Zydus Pharmaceuticals, Mylan and Teva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Budesonide Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Budesonide Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Budesonide Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Budesonide Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Budesonide Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Budesonide Capsules sales, projected growth trends, production technology, application and end-user industry.

Budesonide Capsules Segment by Company

Amneal

Mayne Pharma

Perrigo

Sciecure Pharma

Tillotts Pharma

Zydus Pharmaceuticals

Mylan

Teva

Budesonide Capsules Segment by Type

1mg

2mg

3mg

Budesonide Capsules Segment by Application

Autoimmune Hepatitis

Crohn's Disease

Collagenous Colitis

Budesonide Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Budesonide Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Budesonide Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Budesonide Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1mg Major Manufacturers Table 3. 2mg Major Manufacturers Table 4. 3mg Major Manufacturers Table 5. Global Budesonide Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Autoimmune Hepatitis Major Manufacturers Table 7. Crohn's Disease Major Manufacturers Table 8. Collagenous Colitis Major Manufacturers Table 9. Budesonide Capsules Industry Trends Table 10. Budesonide Capsules Industry Drivers Table 11. Budesonide Capsules Industry Opportunities and Challenges Table 12. Budesonide Capsules Industry Restraints Table 13. Global Budesonide Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Budesonide Capsules Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Budesonide Capsules Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Budesonide Capsules Revenue Market Share by Region (2021-2026) Table 17. Global Budesonide Capsules Revenue Market Share by Region (2027-2032) Table 18. Global Budesonide Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 19. Global Budesonide Capsules Sales by Region (2021-2026) & (W Units) Table 20. Global Budesonide Capsules Sales by Region (2027-2032) & (W Units) Table 21. Global Budesonide Capsules Sales Market Share by Region (2021-2026) Table 22. Global Budesonide Capsules Sales Market Share by Region (2027-2032) Table 23. Global Budesonide Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Budesonide Capsules Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Budesonide Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Budesonide Capsules Sales Market Share by Manufacturers (2021-2026) Table 27. Global Budesonide Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Budesonide Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Budesonide Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Budesonide Capsules Manufacturers, Product Type & Application Table 31. Global Budesonide Capsules Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Budesonide Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Budesonide Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Budesonide Capsules Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Budesonide Capsules Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Budesonide Capsules Revenue Market Share by Type (2021-2026) Table 38. Global Budesonide Capsules Revenue Market Share by Type (2027-2032) Table 39. Global Budesonide Capsules Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 40. Global Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 41. Global Budesonide Capsules Sales by Type (2027-2032) & (W Units) Table 42. Global Budesonide Capsules Sales Market Share by Type (2021-2026) Table 43. Global Budesonide Capsules Sales Market Share by Type (2027-2032) Table 44. Global Budesonide Capsules Price by Type (2021-2026) & (US$/Unit) Table 45. Global Budesonide Capsules Price by Type (2027-2032) & (US$/Unit) Table 46. Global Budesonide Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Budesonide Capsules Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Budesonide Capsules Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Budesonide Capsules Revenue Market Share by Application (2021-2026) Table 50. Global Budesonide Capsules Revenue Market Share by Application (2027-2032) Table 51. Global Budesonide Capsules Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 52. Global Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 53. Global Budesonide Capsules Sales by Application (2027-2032) & (W Units) Table 54. Global Budesonide Capsules Sales Market Share by Application (2021-2026) Table 55. Global Budesonide Capsules Sales Market Share by Application (2027-2032) Table 56. Global Budesonide Capsules Price by Application (2021-2026) & (US$/Unit) Table 57. Global Budesonide Capsules Price by Application (2027-2032) & (US$/Unit) Table 58. Amneal Company Information Table 59. Amneal Business Overview Table 60. Amneal Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Amneal Budesonide Capsules Product Portfolio Table 62. Amneal Recent Development Table 63. Mayne Pharma Company Information Table 64. Mayne Pharma Business Overview Table 65. Mayne Pharma Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Mayne Pharma Budesonide Capsules Product Portfolio Table 67. Mayne Pharma Recent Development Table 68. Perrigo Company Information Table 69. Perrigo Business Overview Table 70. Perrigo Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Perrigo Budesonide Capsules Product Portfolio Table 72. Perrigo Recent Development Table 73. Sciecure Pharma Company Information Table 74. Sciecure Pharma Business Overview Table 75. Sciecure Pharma Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sciecure Pharma Budesonide Capsules Product Portfolio Table 77. Sciecure Pharma Recent Development Table 78. Tillotts Pharma Company Information Table 79. Tillotts Pharma Business Overview Table 80. Tillotts Pharma Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Tillotts Pharma Budesonide Capsules Product Portfolio Table 82. Tillotts Pharma Recent Development Table 83. Zydus Pharmaceuticals Company Information Table 84. Zydus Pharmaceuticals Business Overview Table 85. Zydus Pharmaceuticals Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Zydus Pharmaceuticals Budesonide Capsules Product Portfolio Table 87. Zydus Pharmaceuticals Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Budesonide Capsules Product Portfolio Table 92. Mylan Recent Development Table 93. Teva Company Information Table 94. Teva Business Overview Table 95. Teva Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Teva Budesonide Capsules Product Portfolio Table 97. Teva Recent Development Table 98. North America Budesonide Capsules Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Budesonide Capsules Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 101. North America Budesonide Capsules Sales by Type (2027-2032) & (W Units) Table 102. North America Budesonide Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 103. North America Budesonide Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 104. North America Budesonide Capsules Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Budesonide Capsules Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 107. North America Budesonide Capsules Sales by Application (2027-2032) & (W Units) Table 108. North America Budesonide Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 109. North America Budesonide Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 110. North America Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Budesonide Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Budesonide Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 114. North America Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 115. North America Budesonide Capsules Sales by Country (2027-2032) & (W Units) Table 116. North America Budesonide Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 117. North America Budesonide Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 118. United States Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 119. Canada Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 120. Europe Budesonide Capsules Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Budesonide Capsules Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 123. Europe Budesonide Capsules Sales by Type (2027-2032) & (W Units) Table 124. Europe Budesonide Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Budesonide Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Budesonide Capsules Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Budesonide Capsules Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 129. Europe Budesonide Capsules Sales by Application (2027-2032) & (W Units) Table 130. Europe Budesonide Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Budesonide Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Budesonide Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Budesonide Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 136. Europe Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 137. Europe Budesonide Capsules Sales by Country (2027-2032) & (W Units) Table 138. Europe Budesonide Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Budesonide Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 141. France Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 142. U.K. Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 143. Italy Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 145. China Budesonide Capsules Revenue by Type (2021-2026) & (US$ Million) Table 146. China Budesonide Capsules Revenue by Type (2027-2032) & (US$ Million) Table 147. China Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 148. China Budesonide Capsules Sales by Type (2027-2032) & (W Units) Table 149. China Budesonide Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 150. China Budesonide Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 151. China Budesonide Capsules Revenue by Application (2021-2026) & (US$ Million) Table 152. China Budesonide Capsules Revenue by Application (2027-2032) & (US$ Million) Table 153. China Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 154. China Budesonide Capsules Sales by Application (2027-2032) & (W Units) Table 155. China Budesonide Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 156. China Budesonide Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Budesonide Capsules Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Budesonide Capsules Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 160. Asia Budesonide Capsules Sales by Type (2027-2032) & (W Units) Table 161. Asia Budesonide Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Asia Budesonide Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Asia Budesonide Capsules Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Budesonide Capsules Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 166. Asia Budesonide Capsules Sales by Application (2027-2032) & (W Units) Table 167. Asia Budesonide Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Asia Budesonide Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Budesonide Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Budesonide Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 173. Asia Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 174. Asia Budesonide Capsules Sales by Country (2027-2032) & (W Units) Table 175. Asia Budesonide Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Asia Budesonide Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Japan Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 178. South Korea Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 179. India Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 180. Australia Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 181. China Taiwan Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Budesonide Capsules Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Budesonide Capsules Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 186. SAMEA Budesonide Capsules Sales by Type (2027-2032) & (W Units) Table 187. SAMEA Budesonide Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 188. SAMEA Budesonide Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 189. SAMEA Budesonide Capsules Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Budesonide Capsules Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 192. SAMEA Budesonide Capsules Sales by Application (2027-2032) & (W Units) Table 193. SAMEA Budesonide Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 194. SAMEA Budesonide Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 195. SAMEA Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Budesonide Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Budesonide Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 199. SAMEA Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 200. SAMEA Budesonide Capsules Sales by Country (2027-2032) & (W Units) Table 201. SAMEA Budesonide Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 202. SAMEA Budesonide Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Brazil Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 204. Argentina Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 205. Chile Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 206. Colombia Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 207. Peru Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 209. Israel Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 210. UAE Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 211. Turkey Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 212. Iran Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 213. Egypt Budesonide Capsules Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Budesonide Capsules Distributors List Table 217. Budesonide Capsules Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Budesonide Capsules Image Figure 2. Global Budesonide Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1mg Image Figure 5. 2mg Image Figure 6. 3mg Image Figure 7. Global Budesonide Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Budesonide Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 9. Autoimmune Hepatitis Image Figure 10. Crohn's Disease Image Figure 11. Collagenous Colitis Image Figure 12. Global Budesonide Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Budesonide Capsules Revenue (2021-2032) & (US$ Million) Figure 14. Global Budesonide Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Budesonide Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Budesonide Capsules Revenue Market Share by Region (2021-2032) Figure 17. Global Budesonide Capsules Sales (2021-2032) & (W Units) Figure 18. Global Budesonide Capsules Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 19. Global Budesonide Capsules Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Budesonide Capsules Sales YoY (2021-2032) & (W Units) Figure 21. Europe Budesonide Capsules Sales YoY (2021-2032) & (W Units) Figure 22. China Budesonide Capsules Sales YoY (2021-2032) & (W Units) Figure 23. Asia (Excluding China) Budesonide Capsules Sales YoY (2021-2032) & (W Units) Figure 24. South America, Middle East and Africa Budesonide Capsules Sales YoY (2021-2032) & (W Units) Figure 25. Global Budesonide Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Budesonide Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Budesonide Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Budesonide Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Budesonide Capsules Revenue Market Share by Type (2021-2032) Figure 31. Global Budesonide Capsules Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 32. Global Budesonide Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Budesonide Capsules Sales Market Share by Type (2021-2032) Figure 34. Global Budesonide Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Budesonide Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Budesonide Capsules Revenue Market Share by Application (2021-2032) Figure 37. Global Budesonide Capsules Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Budesonide Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Budesonide Capsules Sales Market Share by Application (2021-2032) Figure 40. North America Budesonide Capsules Revenue Share by Type (2021-2032) Figure 41. North America Budesonide Capsules Sales Share by Type (2021-2032) Figure 42. North America Budesonide Capsules Revenue Share by Application (2021-2032) Figure 43. North America Budesonide Capsules Sales Share by Application (2021-2032) Figure 44. North America Budesonide Capsules Revenue Share by Country (2021-2032) Figure 45. North America Budesonide Capsules Sales Share by Country (2021-2032) Figure 46. Europe Budesonide Capsules Revenue Share by Type (2021-2032) Figure 47. Europe Budesonide Capsules Sales Share by Type (2021-2032) Figure 48. Europe Budesonide Capsules Revenue Share by Application (2021-2032) Figure 49. Europe Budesonide Capsules Sales Share by Application (2021-2032) Figure 50. Europe Budesonide Capsules Revenue Share by Country (2021-2032) Figure 51. Europe Budesonide Capsules Sales Share by Country (2021-2032) Figure 52. China Budesonide Capsules Revenue Share by Type (2021-2032) Figure 53. China Budesonide Capsules Sales Share by Type (2021-2032) Figure 54. China Budesonide Capsules Revenue Share by Application (2021-2032) Figure 55. China Budesonide Capsules Sales Share by Application (2021-2032) Figure 56. Asia Budesonide Capsules Revenue Share by Type (2021-2032) Figure 57. Asia Budesonide Capsules Sales Share by Type (2021-2032) Figure 58. Asia Budesonide Capsules Revenue Share by Application (2021-2032) Figure 59. Asia Budesonide Capsules Sales Share by Application (2021-2032) Figure 60. Asia Budesonide Capsules Revenue Share by Country (2021-2032) Figure 61. Asia Budesonide Capsules Sales Share by Country (2021-2032) Figure 62. SAMEA Budesonide Capsules Revenue Share by Type (2021-2032) Figure 63. SAMEA Budesonide Capsules Sales Share by Type (2021-2032) Figure 64. SAMEA Budesonide Capsules Revenue Share by Application (2021-2032) Figure 65. SAMEA Budesonide Capsules Sales Share by Application (2021-2032) Figure 66. SAMEA Budesonide Capsules Revenue Share by Country (2021-2032) Figure 67. SAMEA Budesonide Capsules Sales Share by Country (2021-2032) Figure 68. Budesonide Capsules Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Budesonide Capsules Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 2mg
  • 3mg
Applications
  • Autoimmune Hepatitis
  • Crohn's Disease
  • Collagenous Colitis
Companies covered
  • Amneal
  • Mayne Pharma
  • Perrigo
  • Sciecure Pharma
  • Tillotts Pharma
  • Zydus Pharmaceuticals
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Budesonide Capsules Market by Type
  3. 1.2.1 Global Budesonide Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1mg
  5. 1.2.3 2mg
  6. 1.2.4 3mg
  7. 1.3 Budesonide Capsules Market by Application
  8. 1.3.1 Global Budesonide Capsules Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Autoimmune Hepatitis
  10. 1.3.3 Crohn's Disease
  11. 1.3.4 Collagenous Colitis
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Budesonide Capsules Market Dynamics
  1. 2.1 Budesonide Capsules Industry Trends
  2. 2.2 Budesonide Capsules Industry Drivers
  3. 2.3 Budesonide Capsules Industry Opportunities and Challenges
  4. 2.4 Budesonide Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Budesonide Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Budesonide Capsules Revenue by Region
  3. 3.2.1 Global Budesonide Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Budesonide Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Budesonide Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Budesonide Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Budesonide Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Budesonide Capsules Sales by Region
  9. 3.4.1 Global Budesonide Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Budesonide Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Budesonide Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Budesonide Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Budesonide Capsules Revenue by Manufacturers
  2. 4.1.1 Global Budesonide Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Budesonide Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Budesonide Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Budesonide Capsules Sales by Manufacturers
  6. 4.2.1 Global Budesonide Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Budesonide Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Budesonide Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Budesonide Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Budesonide Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Budesonide Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Budesonide Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Budesonide Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Budesonide Capsules Market CR5 and HHI
  16. 4.8.2 2025 Budesonide Capsules Tier 1, Tier 2, and Tier 3
5 Budesonide Capsules Market by Type
  1. 5.1 Global Budesonide Capsules Revenue by Type
  2. 5.1.1 Global Budesonide Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Budesonide Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Budesonide Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Budesonide Capsules Sales by Type
  6. 5.2.1 Global Budesonide Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Budesonide Capsules Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Budesonide Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Budesonide Capsules Price by Type
6 Budesonide Capsules Market by Application
  1. 6.1 Global Budesonide Capsules Revenue by Application
  2. 6.1.1 Global Budesonide Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Budesonide Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Budesonide Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Budesonide Capsules Sales by Application
  6. 6.2.1 Global Budesonide Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Budesonide Capsules Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Budesonide Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Budesonide Capsules Price by Application
7 Company Profiles
  1. 7.1 Amneal
  2. 7.1.1 Amneal Company Information
  3. 7.1.2 Amneal Business Overview
  4. 7.1.3 Amneal Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amneal Budesonide Capsules Product Portfolio
  6. 7.1.5 Amneal Recent Developments
  7. 7.2 Mayne Pharma
  8. 7.2.1 Mayne Pharma Company Information
  9. 7.2.2 Mayne Pharma Business Overview
  10. 7.2.3 Mayne Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mayne Pharma Budesonide Capsules Product Portfolio
  12. 7.2.5 Mayne Pharma Recent Developments
  13. 7.3 Perrigo
  14. 7.3.1 Perrigo Company Information
  15. 7.3.2 Perrigo Business Overview
  16. 7.3.3 Perrigo Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Perrigo Budesonide Capsules Product Portfolio
  18. 7.3.5 Perrigo Recent Developments
  19. 7.4 Sciecure Pharma
  20. 7.4.1 Sciecure Pharma Company Information
  21. 7.4.2 Sciecure Pharma Business Overview
  22. 7.4.3 Sciecure Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sciecure Pharma Budesonide Capsules Product Portfolio
  24. 7.4.5 Sciecure Pharma Recent Developments
  25. 7.5 Tillotts Pharma
  26. 7.5.1 Tillotts Pharma Company Information
  27. 7.5.2 Tillotts Pharma Business Overview
  28. 7.5.3 Tillotts Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Tillotts Pharma Budesonide Capsules Product Portfolio
  30. 7.5.5 Tillotts Pharma Recent Developments
  31. 7.6 Zydus Pharmaceuticals
  32. 7.6.1 Zydus Pharmaceuticals Company Information
  33. 7.6.2 Zydus Pharmaceuticals Business Overview
  34. 7.6.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Zydus Pharmaceuticals Budesonide Capsules Product Portfolio
  36. 7.6.5 Zydus Pharmaceuticals Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mylan Budesonide Capsules Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Teva
  44. 7.8.1 Teva Company Information
  45. 7.8.2 Teva Business Overview
  46. 7.8.3 Teva Budesonide Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Teva Budesonide Capsules Product Portfolio
  48. 7.8.5 Teva Recent Developments
8 North America
  1. 8.1 North America Budesonide Capsules Market Size by Type
  2. 8.1.1 North America Budesonide Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Budesonide Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Budesonide Capsules Price by Type (2021-2032)
  5. 8.2 North America Budesonide Capsules Market Size by Application
  6. 8.2.1 North America Budesonide Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Budesonide Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Budesonide Capsules Price by Application (2021-2032)
  9. 8.3 North America Budesonide Capsules Market Size by Country
  10. 8.3.1 North America Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Budesonide Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Budesonide Capsules Market Size by Type
  2. 9.1.1 Europe Budesonide Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Budesonide Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Budesonide Capsules Price by Type (2021-2032)
  5. 9.2 Europe Budesonide Capsules Market Size by Application
  6. 9.2.1 Europe Budesonide Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Budesonide Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Budesonide Capsules Price by Application (2021-2032)
  9. 9.3 Europe Budesonide Capsules Market Size by Country
  10. 9.3.1 Europe Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Budesonide Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Budesonide Capsules Market Size by Type
  2. 10.1.1 China Budesonide Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Budesonide Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Budesonide Capsules Price by Type (2021-2032)
  5. 10.2 China Budesonide Capsules Market Size by Application
  6. 10.2.1 China Budesonide Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Budesonide Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Budesonide Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Budesonide Capsules Market Size by Type
  2. 11.1.1 Asia Budesonide Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Budesonide Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Budesonide Capsules Price by Type (2021-2032)
  5. 11.2 Asia Budesonide Capsules Market Size by Application
  6. 11.2.1 Asia Budesonide Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Budesonide Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Budesonide Capsules Price by Application (2021-2032)
  9. 11.3 Asia Budesonide Capsules Market Size by Country
  10. 11.3.1 Asia Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Budesonide Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Budesonide Capsules Market Size by Type
  2. 12.1.1 SAMEA Budesonide Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Budesonide Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Budesonide Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Budesonide Capsules Market Size by Application
  6. 12.2.1 SAMEA Budesonide Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Budesonide Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Budesonide Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Budesonide Capsules Market Size by Country
  10. 12.3.1 SAMEA Budesonide Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Budesonide Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Budesonide Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Budesonide Capsules Value Chain Analysis
  2. 13.1.1 Budesonide Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Budesonide Capsules Production Mode & Process
  6. 13.2 Budesonide Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Budesonide Capsules Distributors
  9. 13.2.3 Budesonide Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst